Evaluation of an immunohistochemcal combination for diagnosis of prostate adenocarcinoma
LE Xiao-hua,ZHOU Xiao-jun,PAN Min-hong,ZHOU Hang-bo,LU Zhen-feng,GOU Ji-zhou,乐晓华,周晓军,潘敏鸿,周航波,陆珍凤,苟继周
DOI: https://doi.org/10.3760/CMA.J.ISSN.1008-6706.2007.10.025
2007-01-01
Abstract:Objective To investigate the value of immunohistochemcal combination of P504S,PSA,PAP, p63 and 34βE12 for diagnosis Of prostate adenocarcinoma.Methods The expression of P504S,PSA,PAP,p63 and 34βE12 in needle biopsy and transurethral resection specimens from the patients with prostate hyperplasia and prostate adenocarcinoma was detected by immunohistochemistry.Serum PSA was tested by ELISA.Results There were no significant difference in serum PSA level between the prostate hyperplasia group and the prostate adenocarci- noma group(t = 1.91.P = 0.07).The diagnostic sensitivity and specificity of P504S in patients with prostate adeno: carcinoma were 44/46(95.6 %)and 25/26(96.1%),respectively.The positive rates of PSA and PAP in prostate adenocareinoma were 43/45(95.6 %)and 23/23(100 %),respectively.The negative rates of p63 and 34t3E12 in prostate adenocarcinoma were 43/43(100 %)and 19/22(86.4 %),respectively,p63 was negative in 1(4.2 %)of 24 eases of prostate hyperplasia,and 34βE12 was positive in 3(13.6 %)of 22 cases of prostate adenocarcinoma.Between the two groups,the difference of expression of P504S,p63 and 3413E12 was significant(P<0.01),while that of PSA and PAP was not significant(P>0.05).The expression intensity of P504S,PSA and PAP was not correlative with Gleason scores in prostate adenocareinoma(P>0.05).Conclusion The immunohistoehemical combination of P504S,PSA,PAP,p63 and 341βE12 is a good adjuvant method to diagnose prostate adenocarcinoma.